Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive

Gynecologic Oncology

Volumn 120, Issue 1, 2011, Pages 73-83

  Li, Ying ^a   Zeng, Wen Jie ^a   Ye, Feng ^a,b   Wang, Xin Yu ^b   Lü, Wei Guo ^b   Ma, Ding ^c   Wei, Li Hui ^d   Xie, Xing ^b  

^a Women's Reproductive Health Laboratory of Zhejiang Province   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

ASC; Cervical cancer; CIN; HR HPV; HTERC; LSIL

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CENTROMERE; CHROMOSOME 3Q; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TELOMERASE RNA GENE; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RNA GENE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA; TELOMERASE; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 78649906220     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.007     Document Type: Article

References (37)

1. J.G.C. Peto, and F.E. Fletcher The cervical cancer that screening has prevented in the UK Lancet 364 9430 2004 249 256
2. J.W. Bishop, C.J. Marshall, and J.S. Bentz New technologies in gynecologic cytology J Reprod Med 45 9 2000 701 719
3. S.J. Bernstein, L. Sanchez-Ramos, and B. Ndubisi Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy Am J Obstet Gynecol 185 2 2001 308 317
4. O. Abulafia, J.C. Pezzullo, and D.M. Sherer Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey Gynecol Oncol 90 1 2003 137 144
5. D. Solomon, D. Davey, R. Kurman, A. Moriary, D. O'Connor, and M. Prey The 2001 Bethesda System-terminology for reporting results of cervical cytology JAMA 287 16 2002 2114 2119
6. H. zur Hausen Papillomaviruses in human cancers Proc Assoc Am Physicians 111 6 1999 581 587
7. J. Cuzick, M. Arbyn, R. Sankaranarayanan, V. Tsu, G. Ronco, and M.H. Mayrand Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 Suppl 10 2008 K29 K41
8. J. Cuzick, A. Szarewski, H. Cubie, G. Hulman, H. Kitchener, and D. Luesley Management of women who test positive for high-risk types of human papillomavirus: the HART study Lancet 362 9399 2003 1871 1876
9. M.E. Sherman, A.T. Lorincz, D.R. Scott, S. Wacholder, P.E. Castle, and A.G. Glass Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis J Natl Cancer Inst 95 1 2003 46 52
10. S. Kjaer, E. Hogdall, K. Frederiksen, C. Munk, A. van den Brule, and E. Svare The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period Cancer Res 66 21 2006 10630 10636
11. P.E. Gravitt, M. Schiffman, D. Solomon, C.M. Wheeler, and P.E. Castle A comparison of linear array and hybrid capture 2 for detection of carcinogenic HPV, and cervical precancer in ALTS Cancer Epidem Biomar 17 5 2008 1248 1254
12. M. Schiffman, and P.E. Castle Human papillomavirus: epidemiology and public health Arch Pathol Lab Med 127 8 2003 930 934
13. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 7 1998 423 428
14. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836
15. K. Münger, A. Baldwin, K.M. Edwards, H. Hayakawa, C.L. Nguyen, and M. Owens Mechanisms of human papilloma virus-induced oncogenesis J Virol 78 21 2004 11451 11460
16. K. Heselmeyer, E. Schrock, S. du Manoir, H. Blegen, K. Shah, and R. Steinbeck Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix Proc Natl Acad Sci USA 93 1 1996 479 484
17. R.J. Preston Telomeres, telomerase and chromosome stability Radiat Res 147 5 1997 529 534
18. T. Nowak, D. Januszkiewicz, M. Zawada, M. Pernak, K. Lewandowski, and J. Rembowska Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase Oncol Rep 16 2 2006 301 305
19. N.P. Caraway, A. Khanna, M. Dawlett, M. Guo, N. Guo, and E. Lin Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma Gynecol Oncol 110 1 2008 37 42
20. Y. Li, F. Ye, W.-G. Lu, W.-J. Zeng, L.-H. Wei, and X. Xie Detection of human telomerase RNA gene in cervical cancer and precancerous lesions, comparison with cytological and human papillomavirus DNA test findings Int J Gynecol Cancer 20 4 2010 631 637
21. R.J.N.H. Kurman, and E. Wilkinson Tumors of the cervix, vagina, and vulva Atlas of Tumor Pathology. Armed Forces Inst Pathol 1992 37 139
22. J.L. Pretet, V. Dalstein, S. Monnier-Benoit, S. Delpeut, and C. Mougin High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women J Clin Virol 31 2 2004 140 147
23. S.M. Kulmala, S. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, and J. Podistov Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools J Clin Microbiol 42 6 2004 2470 2475
24. M.H. Stoler, and M. Schiffman Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study JAMA 285 11 2001 1500 1505
25. M.J. Difurio, C.T. Thomas Mailhiot, M.J. Sundborg, and K.K. Nauschuetz Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H Diagn Cytopathol 38 5 2010 313 317
26. T.C. Wright, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests Am J Obstet Gynecol 197 4 2007 346 355 (Pubitemid 47464164)
27. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial J Natl Cancer Inst 92 5 2000 397 402
28. D. Solomon, M. Schiffman, and R. Tarone Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial J Natl Cancer Inst 93 4 2001 293 299 (Pubitemid 32219816)
29. M.E. Sherman, D. Solomon, and M. Schiffman Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study Am J Clin Pathol 116 3 2001 386 394
30. Huh W, Einstein MH, Herzog TJ, Franco EL. What is the role of HPV typing in the United States now and in the next five years in a vaccinated population? Gynecol Oncol 2010 Jun;117(3):481-5.
31. J. Cuzick New strategies of cervical cancer screening 2010 EUROGIN
32. R.E. Crookes, M. Dyson, J.F. Smith, and E. Maltby Detection of human telomerase gene (TERC) amplification in cervical neoplasia: a retrospective study of 50 patients with normal smears or mild or moderate dyskaryosis Cytopathology 18 s1 2007 16 - 16
33. W.G. Sui, M.L. Ou, Y. Dai, J.J. Chen, H.J. Lan, and Q. Yan Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma Int J Gynecol Cancer 19 8 2009 1303 1306
34. Z. Tua, A. Zhang, R. Wu, J. Jiang, Y. Li, and N. Wulan Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders Cancer Genet Cytogen 191 1 2009 10 16
35. F. Alameda, B. Espinet, C. Corzo, R. Munoz, B. Bellosillo, and B. Lloveras 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases Hum Pathol 40 10 2009 1474 1478
36. A. Seppo, G.R. Jalali, R. Babkowski, H. Symiakaki, A. Rodolakis, and T. Tafas Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix Gynecol Oncol 114 1 2009 80 83
37. A.T. Lorincz, P.E. Castle, M.E. Sherman, D.R. Scott, A.G. Glass, and S. Wacholder Viral load of human papillomavirus and risk of CIN3 or cervical cancer Lancet 360 9328 2002 228 229